Dexmedetomidine Versus Pentobarbital for Pediatric Procedural Sedation
Status:
Withdrawn
Trial end date:
2010-06-01
Target enrollment:
Participant gender:
Summary
The investigators believe dexmedetomidine will provide superior sedation with reduced side
effects and reduced time to discharge compared with pentobarbital. The investigators have
developed sedation protocols with pentobarbital and dexmedetomidine in our ambulatory
procedure center. These protocols are both routinely used for sedation in our unit. The
investigators propose to study these two protocols in children ages 6 months to 6 years
presenting to the ambulatory procedure center for non-painful procedural sedation. The
investigators will compare failure of sedation, side effect profile, recovery and discharge
times between the two pharmacologic protocols.